Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Ultragenyx Pharmaceu (RARE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
After Yesterday's Decline of 1.34%, Ultragenyx Pharm Offers Investors Better Value

Ultragenyx Pharm (NASDAQ:RARE) traded in a range yesterday that spanned from a low of $62.67 to a high of $65.55. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of...

RARE : 62.87 (-2.84%)
Ultragenyx's (RARE) UX007 Gets Fast Track Status by FDA

Ultragenyx???s (RARE) UX007 receives Fast Track designation and Rare Pediatric Disease designation by the FDA for the treatment of long-chain fatty acid oxidation disorders.

BAYRY : 17.1850 (-0.66%)
RARE : 62.87 (-2.84%)
ANIP : 68.88 (-0.17%)
CLSN : 2.31 (+2.21%)
Ultragenyx Announces UX007 Granted Fast Track Designation and Rare Pediatric Disease Designation by U.S. FDA for Treatment of Long-Chain Fatty Acid Oxidation Disorders

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for serious rare and ultra-rare genetic diseases, today announced that the U.S. Food...

RARE : 62.87 (-2.84%)
Best Relative Performance in the Biotechnology Industry Detected in Shares of Alder Biopharmac (ALDR , ALNY , RARE , VCYT , EXAS )

Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the...

RARE : 62.87 (-2.84%)
ALDR : 12.52 (-2.03%)
ALNY : 80.14 (-5.60%)
Ultragenyx to Present Corporate Update at Analyst and Investor Day on April 17 in New York

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for serious rare and ultra-rare genetic diseases, today announced that management...

RARE : 62.87 (-2.84%)
Global X Launches GNOM ETF to Tap Booming Genomics Space

Having exposure to trending areas like Robotics & AI, e-commerce and IoT, Global X is set to gain from the booming genomics market with the GNOM ETF.

PBE : 51.51 (-0.94%)
ARKG : 32.04 (+0.19%)
RARE : 62.87 (-2.84%)
ILMN : 318.00 (-0.22%)
IBB : 104.19 (-0.90%)
Global X Launches GNOM ETF to Tap Booming Genomics Space

Having exposure to trending areas like Robotics & AI, e-commerce and IoT, Global X is set to gain from the booming genomics market with the GNOM ETF.

PBE : 51.51 (-0.94%)
ARKG : 32.04 (+0.19%)
RARE : 62.87 (-2.84%)
ILMN : 318.00 (-0.22%)
IBB : 104.19 (-0.90%)
Ultragenyx Pharm Set to Possibly Pullback After Yesterday's Rally of 3.50%

Ultragenyx Pharm (NASDAQ:RARE) traded in a range yesterday that spanned from a low of $71.10 to a high of $72.45. Yesterday, the shares gained 3.5%, which took the trading range above the 3-day high...

RARE : 62.87 (-2.84%)
49.2% Return Seen to Date on SmarTrend Ultragenyx Pharm Call (RARE)

SmarTrend identified an Uptrend for Ultragenyx Pharm (NASDAQ:RARE) on January 8th, 2019 at $44.98. In approximately 3 months, Ultragenyx Pharm has returned 49.24% as of today's recent price of $67.13....

RARE : 62.87 (-2.84%)
Ultragenyx Announces Approval of Crysvita(R) (burosumab) in Brazil for the Treatment of X-linked Hypophosphatemia (XLH) in Adults and Children

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for serious rare and ultra-rare genetic diseases, today announced that Brazil's National...

RARE : 62.87 (-2.84%)
New Research Coverage Highlights UnitedHealth Group, Ultragenyx Pharmaceutical, Navistar International, REGENXBIO, Par Pacific, and Athenex -- Consolidated Revenues, Company Growth, and Expectations for 2019

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of UnitedHealth Group Incorporated...

NAV : 34.76 (+0.99%)
ATNX : 10.99 (-2.40%)
RARE : 62.87 (-2.84%)
PARR : 19.09 (-0.21%)
RGNX : 52.31 (-4.40%)
UNH : 220.93 (+1.89%)
Why Is Ultragenyx (RARE) Up 12.4% Since Last Earnings Report?

Ultragenyx (RARE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

RARE : 62.87 (-2.84%)
51.3% Return Seen to Date on SmarTrend Ultragenyx Pharm Call (RARE)

SmarTrend identified an Uptrend for Ultragenyx Pharm (NASDAQ:RARE) on January 8th, 2019 at $44.98. In approximately 2 months, Ultragenyx Pharm has returned 51.29% as of today's recent price of $68.05....

RARE : 62.87 (-2.84%)
Uptrend Call Working As Ultragenyx Pharm Stock Rises 47.9% (RARE)

SmarTrend identified an Uptrend for Ultragenyx Pharm (NASDAQ:RARE) on January 8th, 2019 at $44.98. In approximately 2 months, Ultragenyx Pharm has returned 47.91% as of today's recent price of $66.53....

RARE : 62.87 (-2.84%)
Ultragenyx to Present at Upcoming Investor Conferences

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for serious rare and ultra-rare genetic diseases, today announced that it will present...

RARE : 62.87 (-2.84%)
Ultragenyx Pharm Rises 3.16% on Heavy Volume: Watch For Potential Pullback

Ultragenyx Pharm (NASDAQ:RARE) traded in a range yesterday that spanned from a low of $65.59 to a high of $66.75. Yesterday, the shares gained 3.2%, which took the trading range above the 3-day high...

RARE : 62.87 (-2.84%)
Ultragenyx Announces Proposed Public Offering of Common Stock

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical company focused on the development of novel products for serious rare and ultra-rare genetic diseases, today announced that it has commenced...

RARE : 62.87 (-2.84%)
JPM : 113.84 (-0.40%)
Look for Shares of Ultragenyx Pharm to Potentially Pullback after Yesterday's 7.29% Rise

Ultragenyx Pharm (NASDAQ:RARE) traded in a range yesterday that spanned from a low of $61.00 to a high of $64.68. Yesterday, the shares gained 7.3%, which took the trading range above the 3-day high...

RARE : 62.87 (-2.84%)
33.0% Return Seen to Date on SmarTrend Ultragenyx Pharm Call (RARE)

SmarTrend identified an Uptrend for Ultragenyx Pharm (NASDAQ:RARE) on January 8th, 2019 at $44.98. In approximately 2 month, Ultragenyx Pharm has returned 32.99% as of today's recent price of $59.82.

RARE : 62.87 (-2.84%)
Ultragenyx Announces Positive 24-week Data from First Cohort of Phase 1/2 Study of DTX401 Gene Therapy in Glycogen Storage Disease Type Ia

DTX401 Response in Time to Hypoglycemia and Improved Glucose Control Maintained or Improved in All Three Patients

RARE : 62.87 (-2.84%)

Van Meerten Stock Picks

Trilogy Metals - Pick of the Day
My Stock Pick of the Day belongs metal mining company Trilogy Metals(TMQ).
TMQ +0.07
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar